During the past decade, Sarasota Retina Institute conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 18 clinical trials were completed, i.e. on average, 78.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 14 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sarasota Retina Institute" #1 sponsor was "Jaeb Center for Health Research" with 13 trials, followed by "VisionCare, Inc." with 4 trials sponsored, "Allergan" with 2 trials sponsored, "Clearside Biomedical, Inc." with 2 trials sponsored and "Quark Pharmaceuticals" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sarasota Retina Institute" #1 collaborator was "National Eye Institute (NEI)" with 12 trials as a collaborator, "National Institutes of Health (NIH)" with 6 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 3 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator and "Allergan" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Sarasota Retina Institute" are "Diabetic Macular Edema" (10 trials), "Diabetic Retinopathy" (5 trials), "Macular Degeneration" (3 trials), "Age-related Macular Degeneration" (2 trials) and "Blepharoptosis" (2 trials). Many other conditions were trialed in "Sarasota Retina Institute" in a lesser frequency.

Most popular intervention types in "Sarasota Retina Institute" are "Drug" (27 trials), "Device" (6 trials), "Other" (6 trials), "Procedure" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ranibizumab" (3 trials), "Deferred aflibercept" (2 trials), "Deferred laser" (2 trials) and "IVT aflibercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sarasota Retina Institute" are 36 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Sarasota Retina Institute". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 26 completed trials in Sarasota Retina Institute, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Sarasota Retina Institute, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".